How to Buy Arbutus Biopharma Stock

Arbutus Biopharma Corp

Arbutus Biopharma Corporation, a biopharmaceutical company operating in the United States, focuses on the discovery and development of novel therapies for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses.

Arbutus Biopharma stock last closed at $4.55, up 2.71% from the previous day, and has increased 31.12% in one year. It has overperformed other stocks in the Biotechnology industry by 1.03 percentage points. Arbutus Biopharma stock is currently +49.67% from its 52-week low of $3.04, and -10.78% from its 52-week high of $5.10.

As of Jun 18, 2026, there are 197.54M shares of ABUS outstanding. The market capitalization of ABUS is $898.80M. In the last 24 hours, 5.05M ABUS shares were traded.

How to Buy Arbutus Biopharma Stock

Wondering how to invest in Arbutus Biopharma stock? Here's how.

  1. Decide where to buy Arbutus Biopharma stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Arbutus Biopharma stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your brokerage account: Pick your payment method and add your information.
  4. Analyze Arbutus Biopharma stock: The Arbutus Biopharma ticker symbol is ABUS. Is Arbutus Biopharma stock a good investment? Should you buy shares of ABUS? How do ABUS's underlying business fundamentals look? Do top analysts think Arbutus Biopharma is a good buy? Why has ABUS's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ABUS is a good stock to buy).
  5. Execute your ABUS trade: Decide if you will purchase ABUS shares at the current market price or use a limit order to purchase ABUS stock at a particular price.
  6. Get key alerts regarding your ABUS position: Create a watchlist to keep tabs on your new investment in Arbutus Biopharma stock.

Step 1: Decide where to buy Arbutus Biopharma stock

You will need an online brokerage account in order to access the NASDAQ market and buy ABUS stock.

A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our analysis, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world financial markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (ā€œthe BDā€), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (ā€œthe MSBā€) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've selected your brokerage, the next step is to fill out some personal details so you can buy ABUS stock today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to open your new trading account.
  1. Submit your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you've finished signing up on one of the best stock trading apps, your next step is to transfer the money for your investment:

Check out this video walkthrough if you need help transferring money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Arbutus Biopharma stock

After you have chosen the best place to buy Arbutus Biopharma stock, it's absolutely critical to analyze their stock prior to buying, so you truly wrap your head around the risk and upside.

Arbutus Biopharma Numbers

ABUS Price
$4.55
1w %
6.06%
1y %
31.12%
5y %
40%
P/E
5.42x
P/B
3.45x
P/S
4.61x
PEG
N/A
Revenue
$191.45M
Earnings
$160.72M
Fore. Rev. Growth
-51.46%
Fore. Earn. Growth
-64.12%
Market Cap
$898.80M
Next Earnings
Aug 5, 2026
Next Dividend
N/A

ABUS Fundamentals

WallStreetZen was created to help part-time investors do more accurate fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on ABUS's stock page.

Is ABUS stock undervalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ABUS's intrinsic value.

Using relative valuations ratios:

  • ABUS may be undervalued based on its P/E ratio of 5.42x, relative to Biotechnology industry P/E ratio of 15.77x
  • ABUS may be undervalued based on its P/B ratio of 3.45x, relative to Biotechnology industry P/B ratio of 4.95x

You can access more valuation analysis on ABUS's stock here.

ABUS Financial Health Summary

Passed Financial Due Diligence Checks:

  • ABUS has a low debt to equity ratio of 0.07.
  • There are more short-term assets than short-term liabilities on the ABUS balance sheet.
  • Total ABUS debt is lower than 5 years ago, relative to shareholder equity.
  • ABUS has cash burn of 33992000. It has enough cash and short-term investments to cover this for at least one year.
  • ABUS has $95.23M in cash and short term investments. This is enough to cover its annual cash burn of $33.99M.
  • There are more short-term assets than long-term liabilities on the ABUS balance sheet.
  • ABUS profit margin has gone up from -1,195.9% to 84% in the past year.

You can dive deeper into what analysts are projecting on the Arbutus Biopharma stock forecast page.

ABUS Technical Indicators

SMA10
4.31
SMA20
4.39
SMA50
4.36
SMA100
4.35
SMA200
4.41
MACD
0.01
MACD Signal
-0.01
MACD Histogram
0.02
RSI
59.24
Stochastic %K
64.14
Stochastic %D
50.22
StochRSI %K
82.79
StochRSI %D
65.1

ABUS Growth Metrics

Last year, ABUS revenue was $191.45M. In the last five year, ABUS's revenue has grown by 90.98% per year. This was faster than the Biotechnology industry average of 32.37%.

You can analyze ABUS's earnings and revenue performance here.

Latest Insiders Trades at ABUS

Over the last 12 months, insiders at ABUS have not bought or sold any shares.

Dig into more about who owns ABUS stock here.

Does ABUS stock generate passive income?

No, Arbutus Biopharma doesn't provide an income stream by paying out dividends.

ABUS Social Trading Data

One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Execute your ABUS trade

You have two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are usually the easiest way to buy.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at a particular price, use a limit order.

Click the Open button and your broker will place your order.

If you need additional help with buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get key alerts regarding your ABUS position

Now that you own some ABUS stock, you'll want to stay up-to-date on your stock purchase.

Start a watchlist to track the most important metrics related to your ABUS stock.

ABUS Feed

How to Buy Stock in Arbutus Biopharma

To reiterate, here are the 6 steps to buy stock in Arbutus Biopharma:

  1. Decide where to buy Arbutus Biopharma stock
  2. Open a brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Arbutus Biopharma stock
  5. Execute your ABUS trade
  6. Get key alerts regarding your ABUS position

If you require a online brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest news on your new investment in Arbutus Biopharma, get started below.

NASDAQ: ABUS
$4.55+0.12 (+2.71%)
Updated Jun 18, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: ABUS
$4.55+0.12 (+2.71%)
Updated Jun 18, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Arbutus Biopharma share?

As of Jun 18, 2026, it costs $4.55 to buy one share of Arbutus Biopharma stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.44 shares of ABUS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Arbutus Biopharma stock?

One way to place an order for Arbutus Biopharma stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.